Clinical Report: Assessment of High-Risk Populations for Severe Influenza in Mexico
Overview
This study estimates the size of populations eligible for influenza vaccination in Mexico and evaluates vaccination coverage gaps among at-risk populations from 2010 to 2021. Approximately 12.5 million vaccine doses were administered in 2021.
Background
Influenza poses a substantial risk of morbidity and mortality, particularly among individuals with underlying health conditions. Understanding vaccination coverage among high-risk populations is crucial for public health planning.
Data Highlights
No specific numerical data or trial data presented in the article.
Key Findings
Healthcare service utilization among at-risk populations was consistently lower than notified cases and prevalence estimates.
Vaccination coverage varied significantly across different at-risk populations and remained incomplete from 2010 to 2021.
In 2021, around 12.5 million influenza vaccine doses were administered.
Forecasting analyses indicated a progressive increase in healthcare demand among at-risk populations over time.
Gaps exist between estimated at-risk populations, diagnosed individuals, healthcare utilization, and vaccination coverage.
Clinical Implications
Healthcare providers should be aware of the gaps in influenza vaccination coverage among high-risk populations in Mexico.
Conclusion
The study identifies gaps between estimated at-risk populations, diagnosed individuals, healthcare utilization, and vaccination coverage in Mexico.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
